From: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma
Group
Trend
Decrease
Increase
Total
Response
36
52
88
Non-response
1714
1417
31
5350
6669
119
P value
0.679